CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,796,000 | -8.1% | 4,030,000 | +39.0% | 0.34% | +1.8% |
| Q2 2022 | $5,220,000 | +71.1% | 2,900,000 | +92.1% | 0.33% | +149.2% |
| Q1 2022 | $3,050,000 | +11.4% | 1,510,000 | +49.5% | 0.13% | +40.4% |
| Q4 2021 | $2,738,000 | -68.5% | 1,010,000 | +381.6% | 0.09% | -80.0% |
| Q2 2014 | $8,685,000 | -67.8% | 209,735 | -46.2% | 0.47% | -69.6% |
| Q1 2014 | $26,997,000 | +12.3% | 389,735 | -2.3% | 1.54% | +9.6% |
| Q4 2013 | $24,038,000 | +14.6% | 398,835 | +15.6% | 1.41% | -1.3% |
| Q3 2013 | $20,974,000 | -49.3% | 344,960 | -44.2% | 1.43% | -48.7% |
| Q2 2013 | $41,372,000 | – | 617,678 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |